Medical Equipment & Devices: Q1 FY27 results (April-June 2026)

2 companies have declared Medical Equipment & Devices Q1 FY27 results so far, the latest on 5 Sep 2026.

Across the 1 non-financial companies with a year-ago quarter to compare, sales grew +249.4% and net profit -24.3% year on year, and the combined operating margin narrowed 444 bps to 13.7%.

0% of companies grew net profit.

Updated 12 Oct 2026, 13:03 IST 2 declared 112 due in the next 3 days →

Medical Equipment & Devices Q1 FY27 scoreboard

Sales growth
+249.4%
YoY, 1 companies combined; median +249.4%
Net profit growth
-24.3%
YoY combined; median -24.3%
Operating margin
13.7%
-444 bps YoY
Grew profit
0%
0 turnarounds, 0 into loss
Price since results
+1.4%
median; 50% of 2 stocks up

Latest Medical Equipment & Devices Q1 FY27 results 2

Molbio Diagnostics Limited

MOLBIO · Medical Equipment & Devices · Q1 FY27 · Consolidated · Filed
M Cap
₹16,578 Cr
P/E
—
PEG
—
Since results
+24.4%
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales —— 399——
Operating profit —— 91.6——
OPM % —— 22.9%——
Other income —— 1.4——
Net profit —— 56.6——
PAT margin % —— 14.2%——
EPS (₹) —— 5.02——

Quality of profit

Core 98%Other income & one-offs 2%

Pre-tax profit ₹75.9 Cr: core business ₹74.6 Cr, other income ₹1.4 Cr.

Core profit YoY: —

AI read of the filing Molbio Diagnostics Approves Q1 FY27 Results, Authorizes KMPs for Material Disclosures Neutral
  • Board approved unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
  • Meeting commenced at 11:47 AM and concluded at 04:00 PM on September 5, 2026
  • Four Key Managerial Personnel authorized under Regulation 30(5) for determining disclosure materiality
Full analysis →

Fischer Medical Ventures Limited

FISCHER · Medical Equipment & Devices · Q1 FY27 · Consolidated · Filed
M Cap
₹2,079 Cr
P/E
84.9
PEG
—
Since results
-21.6%
  • Operating margin contracted 444 bps YoY
  • Core business grew faster than reported profit (core profit +125%)
₹ CrYoYQoQ Jun 2026Mar 2026Jun 2025
Sales +249.4%-16.0% 81.997.523.4
Operating profit +164.1%from loss 11.3-3.84.3
OPM % -444 bps+1760 bps 13.7%-3.9%18.2%
Other income -80.1%+92.8% 1.50.87.5
Net profit -24.3%from loss 3.8-12.45.0
PAT margin % -1673 bps+1738 bps 4.6%-12.8%21.4%
EPS (₹) -33.3%from loss 0.06-0.190.09

Quality of profit

Core 81%Other income & one-offs 19%

Pre-tax profit ₹7.8 Cr: core business ₹6.3 Cr, other income ₹1.5 Cr.

Core profit YoY: +125.1% · reported profit -24.3%

Against its own trend ?

TrendActualGap
Sales₹46.9₹81.9 +74.7% above
AI read of the filing Fischer Medical Q1 Standalone Loss Widens to ₹3.5 Cr; Allots 2.05 Cr Shares via Warrants Negative
  • Standalone Q1 revenue fell sharply to ₹72.17 lakhs from ₹454.23 lakhs in June 2025
  • Standalone net loss widened to ₹350.41 lakhs against ₹60.94 lakhs in the year-ago quarter
  • Allotted 2,05,05,909 equity shares of ₹1 each at ₹23.40 per share upon warrant conversion
Full analysis →

Reporting in the next three days

HCL Technologies (Mon 12 Oct), ICICI Prudential (Mon 12 Oct), RBL Bank (Mon 12 Oct), Swan Defence (Mon 12 Oct), Gujarat State (Mon 12 Oct), Swaraj Engines (Mon 12 Oct), Plastiblends India (Mon 12 Oct), UMIYA BUILDCON (Mon 12 Oct), Alkali Metals (Mon 12 Oct), Gradiente Infotainment (Mon 12 Oct), Agri-Tech (India) (Mon 12 Oct), Abhishek Integrations (Mon 12 Oct), Rudra Ecovation (Mon 12 Oct), Newtrac Foods (Mon 12 Oct), Inani Securities (Mon 12 Oct), Neil Industries (Mon 12 Oct), Adroit Industries (Mon 12 Oct), Gammon India (Mon 12 Oct), TYPHOON (Mon 12 Oct), UNIVARTS (Mon 12 Oct), VERONICAPRO (Mon 12 Oct), ICICI Prudential (Tue 13 Oct), Tata Elxsi (Tue 13 Oct), Transformers And Rectifiers (Tue 13 Oct) and 88 more. Full results calendar →

How to read this page

The numbers. Each card is one company's Q1 FY27 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, cash-flow statements with the March results.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI